KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,693,914 | -22.1% | 110,556 | -0.1% | 0.60% | -16.0% |
Q2 2023 | $24,005,000 | -37.8% | 110,698 | -47.9% | 0.71% | -42.8% |
Q1 2023 | $38,564,000 | -15.6% | 212,309 | -8.7% | 1.25% | -24.8% |
Q4 2022 | $45,717,494 | -10.7% | 232,659 | +2.3% | 1.66% | -15.1% |
Q3 2022 | $51,168,000 | +225.8% | 227,483 | +83.2% | 1.96% | +213.5% |
Q2 2022 | $15,706,000 | +6.3% | 124,152 | +6.5% | 0.62% | +27.1% |
Q1 2022 | $14,776,000 | -2.9% | 116,537 | +0.3% | 0.49% | +7.7% |
Q4 2021 | $15,214,000 | +7.0% | 116,136 | -0.1% | 0.46% | +3.9% |
Q3 2021 | $14,216,000 | +3.3% | 116,209 | -3.8% | 0.44% | +7.1% |
Q2 2021 | $13,767,000 | -6.5% | 120,775 | -1.3% | 0.41% | -13.3% |
Q1 2021 | $14,719,000 | +7.8% | 122,426 | -8.9% | 0.47% | +4.6% |
Q4 2020 | $13,652,000 | +33.4% | 134,381 | +1.5% | 0.45% | +1.8% |
Q3 2020 | $10,237,000 | -36.8% | 132,400 | -8.9% | 0.44% | -38.8% |
Q2 2020 | $16,190,000 | +77.3% | 145,257 | +14.5% | 0.73% | +39.1% |
Q1 2020 | $9,133,000 | – | 126,843 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |